About - MemoryAid

The origins of MemoryAid.

Colostrinin™ (the active ingredient within MemoryAid) was developed by scientists over twenty years ago and is a colostrum-derived extract of proline-rich polypeptides. The complex and the peptides are thought to have potential utility in conditions associated with memory loss, the natural ageing of cells, as well as neurodegenerative illnesses such as Alzheimer’s disease, Parkinson’s Disease and Multiple Sclerosis.

Colostrinin™ was originally identified by scientists working in Poland. Early clinical studies dating back to 1995, had indicated a significant potential benefit in the treatment of neurodegenerative conditions. Details of that research can be found at www.regentherapeutics.com.

MemoryAid was formulated and designed for the UK market by Dr Peter Garrod of PRG Nutraceuticals Ltd.
Dr Garrod was educated at the London Hospital, part of the University of London.  He graduated with a BDS. and is a LDS of the Royal College of Surgeons. He was at the forefront of development and use of hard- and soft-tissue lasers in the field of dentistry and for over twenty years has concentrated on advanced cosmetic dental work.

He is Managing Director of PRG Nutraceuticals Ltd, formed in 2009, and secured an exclusive licence to market and distribute the MemoryAid product.

Contact Details

MemoryAid is distributed by Forza Group Limited on behalf of PRG Nutraceuticals Ltd.

Forza Group Ltd
Woodford Coach House
Maidstone Road
Staplehurst
Kent TN12 0RH

PRG Nutraceuticals Ltd
The Bower
High Street
Staplehurst
Kent TN12 0BL